文献速递关节外科

定义翻修全膝关节置换术的术前贫血阈值

Defining Preoperative Anemia Thresholds for Revision Total Knee Arthroplasty.
PubMed 文献 · J Arthroplasty · 2026-01-09

该研究回顾性分析了2019至2024年连续翻修全膝关节置换术患者,采用模拟模型评估基于术前贫血阈值批准或拒绝手术对结局的影响。结果显示,未达到39%或33%血细胞比容阈值的患者,其再入院、输血、非家庭出院和并发症发生率均更高。基于曲线下面积,术中输血的最敏感和特异血细胞比容阈值为33.3%(敏感度86.1%,特异度87.8%)。作者认为设定术前贫血阈值可能有助于减少不良结局。

要点

  • 模拟最严格39%血细胞比容阈值,50.6%患者不符合手术条件,其再入院率18.2% vs 8.4%。
  • 模拟最宽松33%血细胞比容阈值,18.4%患者不符合手术条件,其再入院率23.9% vs 11%。
  • 术中输血的最敏感和特异血细胞比容阈值为33.3%(敏感度86.1%,特异度87.8%)。

核心结论

  • 设定翻修全膝关节置换术的术前贫血阈值可能有助于降低再入院、输血、并发症和非家庭出院的 likelihood。
  • 术前血细胞比容阈值对术中及术后输血率 consistently 显示出高敏感度和阳性预测值。
  • 在可能的情况下优化这些阈值,可能提高成功结局的 likelihood 并最大化价值医疗。

研究设计与样本

  • 回顾性审查2019年至2024年连续翻修全膝关节置换术患者,排除初次全膝关节置换术、无术前血细胞比容和1年随访不完整的患者。
  • 采用模拟模型,序贯使用39%至33%的术前血细胞比容截断值,高于各阈值者为「达到阈值」可手术,低于者为「未达到阈值」不可手术。
  • 评估指标包括术中输血、术后输血、出院去向、90天再入院和并发症,采用曲线下面积确定事件不发生所需的贫血阈值。

主要发现

  • 若采用最严格39%血细胞比容阈值,1,322例中669例(50.6%)未达手术阈值,其再入院率18.2% vs 8.4%、术中输血率13% vs 0.5%、术后输血率26.3% vs 4.1%、非家庭出院率53.8% vs 23.7%、术后并发症率26.8% vs 10.6%,均高于达到阈值者。
  • 若采用最宽松33%血细胞比容阈值,1,322例中243例(18.4%)未达手术阈值,其再入院率23.9% vs 11%、术中输血率31.7% vs 1.2%、术后输血率50.2% vs 7.5%、非家庭出院率74.5% vs 31%、术后并发症率38.7% vs 14.3%,均高于达到阈值者。
  • 基于曲线下面积测试,术中输血的最敏感和特异血细胞比容阈值为33.3%(敏感度86.1%,特异度87.8%)。
  • 血红蛋白阈值呈现类似趋势。

关键数值与推荐

  • 模拟术前血细胞比容阈值范围为39%至33%。
  • 术中输血的最敏感和特异血细胞比容阈值为33.3%(敏感度86.1%,特异度87.8%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In an era of value-based medical management, anemia optimization before revision total knee arthroplasty (TKA) could improve outcomes. Using a simulation model, we evaluated whether outcomes would improve for revision TKA if patients were either approved/denied surgery based on incremental preoperative anemia thresholds. METHODS: We retrospectively reviewed consecutive revision TKA patients from 2019 to 2024. Exclusion criteria were primary TKA, no preoperative hematocrit, and incomplete 1-year follow-up. Simulated preoperative hematocrit cutoff values of 39 to 33% were used in a sequential manner. Preoperative hematocrit values above each threshold "met the threshold" for surgery, while hematocrit values below each threshold "did not meet the threshold" for surgery. Intraoperative transfusion, postoperative transfusion, discharge disposition, 90-day readmission, and complications were evaluated. Area under the curve (AUC) determined anemia thresholds needed for an event not to occur. RESULTS: If the strictest 39% hematocrit threshold was used, 669 of 1,322 (50.6%) patients would not meet the threshold for surgery, with these patients having higher readmissions (18.2 versus 8.4%), intraoperative transfusions (13 versus 0.5%), postoperative transfusions (26.3 versus 4.1%), nonhome discharge (53.8 versus 23.7%), and postoperative complications (26.8 versus 10.6%) compared to counterparts meeting the threshold. If the most lenient 33% hematocrit threshold was used, 243 of 1,322 (18.4%) patients would not meet the threshold for surgery, with higher readmissions (23.9 versus 11%), intraoperative transfusions (31.7 versus 1.2%), postoperative transfusions (50.2 versus 7.5%), nonhome discharge (74.5 versus 31%), and postoperative complications (38.7 versus 14.3%) compared to counterparts meeting the threshold. Based on area under the curve testing, the most sensitive and specific hematocrit threshold was 33.3% for intraoperative transfusion (sensitivity 86.1%, specificity 87.8%). Similar trends were found across hemoglobin thresholds. CONCLUSIONS: Setting preoperative anemia thresholds for revision TKA eligibility may have a role in reducing the likelihood of readmission, transfusion, complications, and nonhome discharge. Preoperative hematocrit thresholds consistently demonstrated high sensitivity and positive predictive value pertaining to intra- and postoperative transfusion rates. Optimization of these thresholds, when possible, may improve the likelihood of a successful outcome and maximize value-based care.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Sutton R, Leipman JH, Linton A, et al. Defining Preoperative Anemia Thresholds for Revision Total Knee Arthroplasty. J Arthroplasty. 2026. PMID: 41520693. doi:10.1016/j.arth.2026.01.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。